Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9779.
-
Caliber Launches Tokenized Investment Offerings for Hyatt Studios HotelsCaliber has launched three new tokenized real estate investment offerings, including two Hyatt Studios hotel developments.
-
Jefferies & Co. Initiates Coverage on Core & Main with Buy RatingJefferies & Co. has initiated research coverage on Core & Main, Inc. with a 'Buy' rating and a price target of $53.
-
UBS Adjusts CubeSmart Price Target to $44 From $38UBS has updated its price target for CubeSmart, raising it to $44 from the previous $38 while maintaining a Neutral rating.
-
BofA Adjusts Price Target on Zions Bancorporation to $65 From $68Bank of America (BofA) has revised its price target for Zions Bancorporation, lowering it from $68 to $65.
-
BofA Securities Adjusts Price Target on UMB Financial to $158BofA Securities has updated its price target for UMB Financial Corporation, raising it from $156 to $158.
-
Lemonade Expands Renters Insurance to Minnesota, Completing Nationwide AvailabilityLemonade, Inc. has launched its renters insurance product in Minnesota, achieving full availability across all 50 U.S. states and Washington, D.C.
-
D-Wave Quantum Enhances Stride Hybrid Solver and Launches Developer TrainingD-Wave Quantum has upgraded its Stride hybrid solver with improved benchmark performance and introduced a new developer training curriculum.
-
Analysts Adjust Price Targets for Duolingo Following Third-Quarter ResultsFollowing the release of third-quarter financial results, several financial institutions updated their price targets and ratings for Duolingo, Inc.
-
RBC Capital Markets Raises Price Target on UDR to $38RBC Capital Markets has increased its price target for UDR, Inc. from $37 to $38 while maintaining a Sector Perform rating.
-
FactSet Analyst Target Price Adjustment for TFI International Inc.Analysts have adjusted the median target price for TFI International Inc. (TFII) to 127.76, reflecting a 3.94% change based on the latest FactSet survey.
-
Analysts Update Price Targets for Cinemark Holdings, Inc.Several financial institutions, including StoneX, Deutsche Bank, Wedbush, and MoffettNathanson, adjusted their price targets for Cinemark Holdings, Inc. on November 4, 2026.
-
Deutsche Bank Adjusts Celanese Price Target to $60 From $55, Maintains Buy RatingDeutsche Bank has raised its price target for Celanese Corporation from $55 to $60 while maintaining a Buy rating.
-
BofA Securities Adjusts Price Target on Celanese to $66 From $63BofA Securities has increased its price target for Celanese Corporation from $63 to $66.
-
Celanese Partners With Rochling to Expand Lower-Carbon POM ApplicationsCelanese Corporation has entered a collaboration with Rochling Industrial to advance the use of lower-carbon polyoxymethylene (POM) solutions in stock shape applications.
-
HC Wainwright & Co. Maintains Buy Rating and Raises Price Target for Mirum PharmaceuticalsHC Wainwright & Co. reaffirmed its 'Buy' rating on Mirum Pharmaceuticals and increased its 12-month price target for the company's stock to $202 from $200.
-
Cantor Fitzgerald Maintains Overweight Rating and Raises Price Target for Mirum PharmaceuticalsCantor Fitzgerald reaffirmed its 'Overweight' rating on Mirum Pharmaceuticals and increased its 12-month price target for the company's stock to $160 from $155.
-
Dianthus Therapeutics, Inc. Scheduled to Announce Q3 2026 Financial ResultsDianthus Therapeutics, Inc. is scheduled to release its financial results for the third quarter of 2026 on November 5, 2026.
-
Piper Sandler Resumes Coverage of Supernus Pharmaceuticals Following Indivior Merger AnnouncementPiper Sandler initiated coverage of Supernus Pharmaceuticals with an overweight rating, highlighting the strategic benefits of its pending merger with Indivior.
-
Enova International, Inc. Announces Private Offering of $600 Million of Senior Notes Due 2031Enova International, Inc. has announced its intention to offer $600 million in aggregate principal amount of senior notes due 2031 to refinance existing debt.
-
RBC Capital Markets Notes Favorable Outlook for Sotera Health Heading Into 2027RBC Capital Markets has highlighted a favorable setup for Sotera Health as the company approaches 2027, citing a clean balance sheet and strong free cash flow profile.